HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer Takes On NAD In All-Day Energy Claims Challenge Brought By Wyeth

This article was originally published in The Tan Sheet

Executive Summary

Bayer Healthcare will take a second opportunity to present evidence for the continued use of the All-Day Energy brand for its multivitamin product, according to a July 12 decision by the National Advertising Division of the Council of Better Business Bureaus

You may also be interested in...



Bayer Will Change ‘All-Day’ Vitamin Name Following Ad Board Decision

Bayer Healthcare will change the name of itsAll-Day Energy multivitamin/multimineral product under the One-A-Day line in response to recommendations from the National Advertising Review Board

Bayer “Cannot Accept” NAD Standard On Health Claims

Bayer Healthcare says it "cannot accept" the standard the National Advertising Division used to judge the validity of claims about the benefits of vitamin B and ginkgo biloba the firm used in a television ad for its Vital and Sharp Mind dietary supplement

Do Not Disrespect NAD: FTC Stresses Compliance With Self-Regulatory Groups

The decision by the maker of Sunpill sunscreen tablets not to comply with the National Advertising Division's recommendations to change its advertising claims is an uncommon response that will get the Federal Trade Commission's attention, Lesley Fair, senior attorney in FTC's Division of Consumer Education, says

Related Content

Topics

UsernamePublicRestriction

Register

RS138055

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel